Kent lake issues letter to quanterix shareholders regarding opposition to the company's proposed merger with akoya biosciences

Rincon, puerto rico--(business wire)--kent lake pr llc (“kent lake”), a holder of 5.9% of the outstanding common stock of quanterix corporation (“quanterix” or the “company”) (nasdaq: qtrx), today highlighted its opposition to the company's proposed merger (the “merger”) with akoya biosciences (“akoya”) (nasdaq: akya). kent lake has also issued an open letter to all quanterix shareholders outlining how the merger significantly undervalues the company and its intention to take all necessary step.
AKYA Ratings Summary
AKYA Quant Ranking